282 related articles for article (PubMed ID: 25722117)
1. Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation.
Park M; Kim YH; Woo SY; Lee HJ; Yu Y; Kim HS; Park YS; Jo I; Park JW; Jung SC; Lee H; Jeong B; Ryu KH
Sci Rep; 2015 Feb; 5():8616. PubMed ID: 25722117
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
Seo KW; Sohn SY; Bhang DH; Nam MJ; Lee HW; Youn HY
Cell Biol Int; 2014 Jan; 38(1):106-16. PubMed ID: 24115681
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
Motawi TM; Atta HM; Sadik NA; Azzam M
Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
[TBL] [Abstract][Full Text] [Related]
4.
Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
[TBL] [Abstract][Full Text] [Related]
6. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
Kim J; Lee C; Shin Y; Wang S; Han J; Kim M; Kim JM; Shin SC; Lee BJ; Kim TJ; Jung Y
Mol Ther; 2021 Apr; 29(4):1471-1486. PubMed ID: 33348053
[TBL] [Abstract][Full Text] [Related]
7. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis.
Ren H; Zhao Q; Cheng T; Lu S; Chen Z; Meng L; Zhu X; Yang S; Xing W; Xiao Y; Ren Q; Chi Y; Gu D; Yang R; Han ZC
Cytotherapy; 2010 May; 12(3):371-83. PubMed ID: 20184502
[TBL] [Abstract][Full Text] [Related]
8. Autophagy inhibition via Becn1 downregulation improves the mesenchymal stem cells antifibrotic potential in experimental liver fibrosis.
Wang HY; Li C; Liu WH; Deng FM; Ma Y; Guo LN; Kong H; Hu KA; Liu Q; Wu J; Sun J; Liu YL
J Cell Physiol; 2020 Mar; 235(3):2722-2737. PubMed ID: 31508820
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.
Baligar P; Mukherjee S; Kochat V; Rastogi A; Mukhopadhyay A
Stem Cells; 2016 Jan; 34(1):135-47. PubMed ID: 26389810
[TBL] [Abstract][Full Text] [Related]
10. Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue.
Mohsin S; Shams S; Ali Nasir G; Khan M; Javaid Awan S; Khan SN; Riazuddin S
Differentiation; 2011 Jan; 81(1):42-8. PubMed ID: 20943307
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
[TBL] [Abstract][Full Text] [Related]
12. Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism.
Jung J; Choi JH; Lee Y; Park JW; Oh IH; Hwang SG; Kim KS; Kim GJ
Stem Cells; 2013 Aug; 31(8):1584-96. PubMed ID: 23592412
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte-like Versus Mesenchymal Stem Cells in CCl4-induced Liver Fibrosis.
Ewida SF; Abdou AG; El-Rasol Elhosary AA; El-Ghane Metawe SA
Appl Immunohistochem Mol Morphol; 2017; 25(10):736-745. PubMed ID: 27153445
[TBL] [Abstract][Full Text] [Related]
14. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury.
Xu H; Qian H; Zhu W; Zhang X; Yan Y; Mao F; Wang M; Xu H; Xu W
Exp Biol Med (Maywood); 2012 May; 237(5):585-92. PubMed ID: 22678013
[TBL] [Abstract][Full Text] [Related]
16. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury.
Ryu KH; Kim SY; Kim YR; Woo SY; Sung SH; Kim HS; Jung SC; Jo I; Park JW
Exp Cell Res; 2014 Aug; 326(1):143-54. PubMed ID: 24954408
[TBL] [Abstract][Full Text] [Related]
17. Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration.
Park S; Choi Y; Jung N; Yu Y; Ryu KH; Kim HS; Jo I; Choi BO; Jung SC
Int J Mol Med; 2016 May; 37(5):1209-20. PubMed ID: 27035161
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor.
Tang WP; Akahoshi T; Piao JS; Narahara S; Murata M; Kawano T; Hamano N; Ikeda T; Hashizume M
J Gastroenterol Hepatol; 2015 Jun; 30(6):1065-74. PubMed ID: 25639333
[TBL] [Abstract][Full Text] [Related]
19. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.
Lou G; Yang Y; Liu F; Ye B; Chen Z; Zheng M; Liu Y
J Cell Mol Med; 2017 Nov; 21(11):2963-2973. PubMed ID: 28544786
[TBL] [Abstract][Full Text] [Related]
20. How important is differentiation in the therapeutic effect of mesenchymal stromal cells in liver disease?
Wang H; Zhao T; Xu F; Li Y; Wu M; Zhu D; Cong X; Liu Y
Cytotherapy; 2014 Mar; 16(3):309-18. PubMed ID: 24239106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
